Metabolites in aging and aging-relevant diseases: Frailty, sarcopenia and cognitive decline

被引:5
|
作者
Kondoh, Hiroshi [1 ]
Kameda, Masahiro [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Geriatr Unit, 54 Kawaharacho,Sakyo Ku, Kyoto, Kyoto 6068507, Japan
关键词
aging; frailty; metabolites; LIFE-SPAN; RESTRICTION; SIMILARITIES; RAPAMYCIN;
D O I
10.1111/ggi.14684
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Aging shows biologically complex features with high individual variability, which reflects the exposure to several stimuli and the adaptation to them. Among them, metabolic changes are well observed as consequences or possible causes of aging. Calorie restriction extends organismal life span in experimental models. Several metabolites; for example, resveratrol or nicotinamide mononucleotide, are reported to mimic calorie restriction effects in vivo. Metabolomic research would be useful to evaluate metabolites as biomarkers in aging-relevant events and to identify metabolic regulation of aging. We recently developed the metabolomic approach for whole blood analysis, which functions as strong tool for this purpose. We review the update findings in aging-relevant metabolites detected by this method. Geriatr Gerontol Int 2023; center dot center dot: center dot center dot-center dot center dot. Metabolic changes are well observed as consequences or possible causes of aging, a highly complex biological process. Metabolomics evaluate metabolites as biomarkers in aging-relevant events and aging. We review the update findings in aging-relevant metabolites detected by our whole blood metabolomics.image
引用
收藏
页码:44 / 48
页数:5
相关论文
共 50 条
  • [31] The effects of aging in the hippocampus and cognitive decline
    Bettio, Luis E. B.
    Rajendran, Luckshi
    Gil-Mohapel, Joana
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2017, 79 : 66 - 86
  • [32] Editorial: Sarcopenia and frailty: the role of physical activity for better aging
    Sampaio, Ricardo Aurelio Carvalho
    Sampaio, Priscila Yukari Sewo
    Capelo, Luciane Portas
    Uchida, Marco Carlos
    Arai, Hidenori
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [33] Aging, frailty and age-related diseases
    Fulop, T.
    Larbi, A.
    Witkowski, J. M.
    McElhaney, J.
    Loeb, M.
    Mitnitski, A.
    Pawelec, G.
    BIOGERONTOLOGY, 2010, 11 (05) : 547 - 563
  • [34] Aging, frailty and age-related diseases
    T. Fulop
    A. Larbi
    J. M. Witkowski
    J. McElhaney
    M. Loeb
    A. Mitnitski
    G. Pawelec
    Biogerontology, 2010, 11 : 547 - 563
  • [35] Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer’s disease
    Shuaipeng Ma
    Tong Zang
    Meng-Lu Liu
    Chun-Li Zhang
    Molecular Neurodegeneration, 15
  • [36] Aging-relevant human basal forebrain cholinergic neurons as a cell model for Alzheimer's disease
    Ma, Shuaipeng
    Zang, Tong
    Liu, Meng-Lu
    Zhang, Chun-Li
    MOLECULAR NEURODEGENERATION, 2020, 15 (01)
  • [37] Technological Development in Preventing Cognitive Frailty, Promoting Active Aging, and the Economics of Aging
    Nieto-Vieites, Ana
    Gaspar, Pedro
    Victor, Jose
    Perez-Blanco, Lucia
    Felpete-Lopez, Alba
    Facal, David
    MARKETING AND SMART TECHNOLOGIES, ICMARKTECH 2021, VOL 2, 2022, 280 : 213 - 223
  • [38] Anxiety, cognitive performance, and cognitive decline in normal aging
    Wetherell, JL
    Reynolds, CA
    Gatz, M
    Pedersen, NL
    JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2002, 57 (03): : P246 - P255
  • [39] Nutritional cognitive neuroscience of aging: Focus on carotenoids and cognitive frailty
    Polidori, M. Cristina
    Stahl, Wilhelm
    Griffiths, Helen R.
    REDOX BIOLOGY, 2021, 44
  • [40] Muscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
    Maurizio Muscaritoli
    Simone Lucia
    Alessio Molfino
    Tommy Cederholm
    Filippo Rossi Fanelli
    Internal and Emergency Medicine, 2013, 8 : 553 - 560